Commercialisation Executive, Faculty of Medicine

Louie Scott is a Commercialisation Executive within Imperial Enterprise, supporting innovations arising from the Faculty of Medicine. He works closely with academics and researchers across MedTech, Digital Healthcare, AI for Healthcare and Diagnostic Devices—guiding the assessment, protection and commercialisation of Imperial’s medical technologies through licensing and spin-out creation.

Louie holds a PhD in Veterinary Medicine from the University of Surrey, where he developed carbon nanotube-based tissue scaffolds for cardiac applications in partnership with Advanced Material Development. He also holds a BSc (Hons) in Biochemistry and brings industry experience from GlaxoSmithKline and Pfizer, combining scientific insight with commercial focus to advance healthcare innovation.

Louie's portfolio

Discover all technologies

Filter system for the removal of haemolytic products from blood

A filter matrix for selective removal of haemoglobin, haem, and free iron to mitigate haemolysis-related complications.

SIMPLE: Single Incision Micro Ports Laparoscopic Endo-surgery

A next-generation single-port surgical robotics platform featuring bimanual haptics and support for autonomous ultra-minimally invasive tasks.

Wide clip and applicator for minimally invasive surgery

A rotative surgical clip and applicator designed for minimally invasive clamping of large anatomical regions.

EndoDrone: Endoscopic scanning probe device for rapid screening of hollow organs dysplasia

EndoDrone is a robotic optical biopsy platform enabling automated, real-time classification of wide GI tissue areas.

Use of Capsaicin/TRPV1 agonists for prevention of diabetic foot ulcers

Topical use of Capsaicin or TRPV 1 agonists for the prevention of diabetic ulcers in a patients with diabetic peripheral neuropathy (DPN).

Microbubble-contrast ultrasound imaging of microvasculature to treat male and female reproductive disorders

Microbubble-enhanced ULM system for automated imaging and biomarker analysis of reproductive microvasculature in fertility diagnostics.

Microbial Peptides for the Therapeutic Modulation of the Human Gut-Brain Axis

Peptides derived from the healthy human gut microbiome indicated for modulation of the gut-brain axis in mood and GI disorders.

In situ RTQuIC seeding amplification assay for neurodegeneration

A spatially resolved seeding amplification assay for visualising protein misfolding in neurodegeneration and disease cross-seeding.

Non-Pneumatic Particle Jamming for Low-Cost, Compact Haptic Feedback Devices

Non-pneumatic particle jamming methods for simulated hardness in haptic devices used in VR/AR, robotics, and simulation.